Meige syndrome is a segmental form of dystonia. It is a disabling disease, especially when refractory to treatment with botulinum toxin. A well-established therapeutic option is deep brain stimulation (DBS), and the target in bilateral globus pallidus internus (GPi DBS) demonstrated satisfactory short- and long-term efficacy. However, some patients present minor or suboptimal responses after GPi DBS, and in those cases, rescue DBS may be appropriate. The present case illustrates a good outcome after subthalamic nucleus (STN) and not after GPi DBS (considering that both were well positioned and had adequate programming). The larger dimension of the GPi and its somatotopic organization, with the stimulation outside the “face region,” could explain our outcomes.

1.
Horn
A
,
Kühn
AA
.
Lead-DBS: a toolbox for deep brain stimulation electrode localizations and visualizations
.
Neuroimage
.
2015 Feb 15
;
107
:
127
35
. .
2.
Pauls
KAM
,
Krauss
JK
,
Kämpfer
CE
,
Kühn
AA
,
Schrader
C
,
Südmeyer
M
,
Causes of failure of pallidal deep brain stimulation in cases with pre-operative diagnosis of isolated dystonia
.
Parkinsonism Relat Disord
.
2017 Oct
;
43
:
38
48
. .
3.
Wang
X
,
Mao
Z
,
Cui
Z
,
Xu
X
,
Pan
L
,
Liang
S
,
Predictive factors for long-term clinical outcomes of deep brain stimulation in the treatment of primary Meige syndrome
.
J Neurosurg
.
2019 Apr 5
;
132
(
5
):
1367
75
. .
4.
Yao
C
,
Horn
A
,
Li
N
,
Lu
Y
,
Fu
Z
,
Wang
N
,
Post-operative electrode location and clinical efficacy of subthalamic nucleus deep brain stimulation in Meige syndrome
.
Parkinsonism Relat Disord
.
2019 Jan
;
58
:
40
5
. .
5.
Vayssiere
N
,
van der Gaag
N
,
Cif
L
,
Hemm
S
,
Verdier
R
,
Frerebeau
P
,
Deep brain stimulation for dystonia confirming a somatotopic organization in the globus pallidus internus
.
J Neurosurg
.
2004 Aug
;
101
(
2
):
181
8
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.